Biomedical application of plasmid DNA in gene therapy: A new challenge for chromatography

Biotechnology and Genetic Engineering Reviews

Volumn 26, Issue 1, 2009, Pages 83-116

  Sousa, F ^a   Passarinha, L ^a   Queiroz, J A ^a  

^a UNIVERSITY OF BEIRA INTERIOR   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVITY; CHROMATOGRAPHY; DISEASE CONTROL; DNA; ESCHERICHIA COLI; GENE THERAPY; MEDICAL APPLICATIONS; PURIFICATION;

BIOMEDICAL APPLICATIONS; BIOPHARMACEUTICALS; CONDITION; DNA STABILITY; DNA VACCINATION; E. COLI; MANUFACTURING PROCESS; PLASMID DNA; PRODUCTION PROCESS; THERAPEUTIC EFFECTS;

BIOMOLECULES;

DNA VACCINE; GLYCOPROTEIN GP 100; PLASMID DNA; PROTEIN P53;

AFFINITY CHROMATOGRAPHY; ANION EXCHANGE CHROMATOGRAPHY; CANCER GENE THERAPY; CHROMATOGRAPHY; CLINICAL TRIAL; DNA IMMUNIZATION; DNA ISOLATION; DNA PURIFICATION; DNA STRUCTURE; DNA SYNTHESIS; DNA TRANSFER; FED BATCH FERMENTATION; GEL FILTRATION CHROMATOGRAPHY; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; INFLUENZA; INTERMETHOD COMPARISON; ION EXCHANGE CHROMATOGRAPHY; LYSIS; MALARIA; MELANOMA; MOLECULAR MECHANICS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; REVIEW; VIRUS INFECTION;

EID: 77749249237     PISSN: 02648725     EISSN: 20465556     Source Type: Journal    
DOI: 10.5661/bger-26-83     Document Type: Article

References (150)

1. Alton, E.W., Stern, M., Farley, R., 1999. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis:a double-blind placebo-controlled trial. Lancet, 353:947–54.
2. Anderson, R.J., and Schneider, J., 2007. Plasmid DNA and viral vector-based vaccines for the treatment of cancer. Vaccine, 25:B24–34.
3. Barbosa, H., Hine, A. V., Brocchini, S., Slater, N.K., and Marcos, J.C., 2008. Affinity partitioning of plasmid DNA with a zinc finger protein. Journal of Chromatography A, 1206:105–12.
4. Bencina, M., Podgornik, A., and Strancar, A., 2004. Characterization of methacrylate monoliths for purification of DNA molecules. Journal of Separation Science, 27:801–10.
5. Birnboim, H.C., and Doly, J., 1979. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Research, 7:1513–23.
6. Brannon-Peppas, L., Ghosn, B., Roy, K., and Cornetta, K., 2007. Encapsulation of nucleic acids and opportunities for cancer treatment. Pharmaceutical Research, 24:618–27.
7. Branovic, K., Forcic, D., Ivancic, J., 2004. Application of short monolithic columns for fast purification of plasmid DNA. Journal of Chromatography B, 801:331–7.
8. Braun, S., 2008. Muscular gene transfer using nonviral vectors. Current Gene Therapy, 8:391–405.
9. Brave, A., Ljungberg, K., Wahren, B., and Liu, M.A., 2007. Vaccine delivery methods using viral vectors. Molecular Pharmaceutics, 4:18–32.
10. Bywater, M., Bywater, R., and Hellman, L., 1983. A novel chromatographic procedure for purification of bacterial plasmids. Analytical Biochemistry, 132:219–24.
11. Cano, T., Murphy, J. C., Fox, G.E., and Willson, R.C., 2005. Separation of genomic DNA from plasmid DNA by selective renaturation with immobilized metal affinity capture. Biotechnology Progress, 21:1472–7.
12. Carnes, A.E. (2007). Fermentation process for continuous plasmid production. WO 2007/089873
13. Carnes, A.E., Hodgson, C.P., and Williams, J.A., 2006. Inducible Escherichia coli fermentation for increased plasmid DNA production. Biotechnology and Applied Biochemistry, 45:155–66.
14. Carnes, A.E., and Williams, J.A., 2006. Media and process for plasmid DNA fermentation. PCT/US05/029238
15. Carnes, A.E., and Williams, J.A., 2007. Plasmid DNA manufacturing technology. Recent Patents on Biotechnology, 1:151–66.
16. Chan, G., Booth, A. J., Mannweiler, K., and Hoare, M., 2006. Ultra scaledown studies of the effect of flow and impact conditions during E. coli cell processing. Biotechnology and Bioengineering, 95:671–83.
17. Chandra, G., Patel, P., Kost, T.A., and Gray, J.G., 1992. Large-scale purification of plasmid DNA by fast protein liquid chromatography using a Hi-Load Q Sepharose column. Analytical Biochemistry, 203:169–72.
18. Chang, C.W., Christensen, L. V., Lee, M., and Kim, S.W., 2008. Efficient expression of vascular endothelial growth factor using minicircle DNA for angiogenic gene therapy. Journal of Controlled Release, 125:155–63.
19. CHARTRAIN, M., KIZER L. E. KRULEWICZ, B.A. ET AL. (2005). Process for large-scale production of plasmid DNA by E. coli fermentation. WO/2005/078115
20. Cherng, J.Y., Schuurmans-Nieuwenbroek, N.M., Jiskoot, W., 1999. Effect of DNA topology on the transfection efficiency of poly((2-dimethylamino)ethyl methacrylate)-plasmid complexes. Journal of Controlled Release, 60:343–53.
21. Clark, D.P., 2005. Molecular Biology - Understanding the Genetic Revolution, Elsevier, Academic Press.
22. Clemson, M., and Kelly, W.J., 2003. Optimizing alkaline lysis for DNA plasmid recovery. Biotechnology and Applied Biochemistry, 37:235–44.
23. Cooke, J.R., Mckie, E. A., Ward, J.M., and Keshavarz-Moore, E., 2004. Impact of intrinsic DNA structure on processing of plasmids for gene therapy and DNA vaccines. Journal of Biotechnology, 114:239–54.
24. Cupillard, L., Juillard, V., Latour, S., 2005. Impact of plasmid supercoiling on the efficacy of a rabies DNA vaccine to protect cats. Vaccine, 23:1910–6.
25. Darby, R.A., Forde, G. M., Slater, N.K., and Hine, A.V., 2007. Affinity purification of plasmid DNA directly from crude bacterial cell lysates. Biotechnology and Bioengineering, 98:1103–8.
26. Deshmukh, N.R., and Lali, A.M., 2005. Adsorptive purification of pDNA on superporous rigid cross-linked cellulose matrix. Journal of Chromatography B, 818:5–10.
27. Diogo, M.M., Queiroz, J. A., Monteiro, G.A., and Prazeres, D.M.F., 1999. Separation and analysis of plasmid denatured forms using hydrophobic interaction chromatography. Analytical Biochemistry, 275:122–4.
28. Diogo, M.M., Queiroz, J. A., Monteiro, G.A., 2000. Purification of a cystic fibrosis plasmid vector for gene therapy using hydrophobic interaction chromatography. Biotechnology and Bioengineering, 68:576–83.
29. Diogo, M.M., Queiroz, J.A., and Prazeres, D.M.F., 2001a. Studies on the retention of plasmid DNA and Escherichia coli nucleic acids by hydrophobic interaction chromatography. Bioseparation, 10:211–20.
30. Diogo, M.M., Ribeiro, S. C., Queiroz, J.A., 2001b. Production, purification and analysis of an experimental DNA vaccine against rabies. Journal of Gene Medicine, 3:577–84.
31. Diogo, M.M., Queiroz, J.A., and Prazeres, D.M.F., 2003. Assessment of purity and quantification of plasmid DNA in process solutions using high-performance hydrophobic interaction chromatography. Journal of Chromatography A, 998:109–17.
32. Diogo, M.M., Queiroz, J.A., and Prazeres, D.M.F., 2005. Chromatography of plasmid DNA. Journal of Chromatography A, 1069:3–22.
33. Drape, R.J., Macklin, M. D., Barr, L.J., 2006. Epidermal DNA vaccine for influenza is immunogenic in humans. Vaccine, 24:4475–81.
34. Eon-Duval, A., Macduff, R. H., Fisher, C. A., Harris, M.J., and Brook, C., 2003. Removal of RNA impurities by tangential flow filtration in an RNase-free plasmid DNA purification process. Analytical Biochemistry, 316:66–73.
35. Eon-Duval, A., and Burke, G., 2004. Purification of pharmaceutical-grade plasmid DNA by anion-exchange chromatography in an RNase-free process. Journal of Chromatography B, 804:327–35.
36. Feliciello, I., and Chinali, G., 1993. A modified alkaline lysis method for the preparation of highly purified plasmid DNA from Escherichia coli. Analytical Biochemistry, 212:394–401.
37. Ferreira, G.N., Cabral, J.M., and Prazeres, D.M.F., 1997. A comparison of gel filtration chromatographic supports for plasmid purification. Biotechnology Techniques, 11:417–420.
38. Ferreira, G.N., Cabral, J.M., and Prazeres, D.M.F., 1999. Development of process flow sheets for the purification of supercoiled plasmids for gene therapy applications. Biotechnology Progress, 15:725–31.
39. Ferreira, G.N., Monteiro, G. A., Prazeres, D.M.F., and Cabral, J.M., 2000. Downstream processing of plasmid DNA for gene therapy and DNA vaccine applications. Trends in Biotechnology, 18:380–8.
40. Flores, S., De Anda-Herrera, R., Gosset, G., and Bolivar, F.G., 2004. Growth-rate recovery of Escherichia coli cultures carrying a multicopy plasmid, by engineering of the pentose-phosphate pathway. Biotechnology and Bioengineering, 87:485–94.
41. Forde, G.M., Ghose, S., Slater, N.K., 2006. LacO-LacI interaction in affinity adsorption of plasmid DNA. Biotechnology and Bioengineering, 95:67–75.
42. Giovannini, R., Freitag, R., and Tennikova, T.B., 1998. High-performance membrane chromatography of supercoiled plasmid DNA. Analytical Chemistry, 70:3348–54.
43. Guo, Z.S., Li, Q., Bartlett, D. L., Yang, J.Y., and Fang, B., 2008. Gene transfer:the challenge of regulated gene expression. Trends in Molecular Medicine, 14:410–8.
44. Gurunathan, S., Klinman, D.M., and Seder, R.A., 2000. DNA vaccines:immunology, application, and optimization. Annual Review of Immunology, 18:27–74.
45. Gustavsson, P.E., Axelsson, A., and Larsson, P.O., 1999. Superporous agarose beads as a hydrophobic interaction chromatography support. Journal of Chromatography A, 830:275–284.
46. Gustavsson, P.E., Lemmens, R., Nyhammar, T., Busson, P., and Larsson, P.O., 2004. Purification of plasmid DNA with a new type of anion-exchange beads having a non-charged surface. Journal of Chromatography A, 1038:131–40.
47. Hamann, C.J., Nielsen, J., and Ingerslev, E., 2000. Novel plasmids for use in medicine and method of producing same. WO.:00/28048
48. Han, Y., and Forde, G.M., 2008. Single step purification of plasmid DNA using peptide ligand affinity chromatography. Journal of Chromatography B, 874:21–6.
49. Hasche, A, and Voss, C., 2005. Immobilisation of a repressor protein for binding of plasmid DNA. Journal of Chromatography A, 1080:76–82.
50. Hilbrig, F., Freitag, R., and Schmacher, I., 2004. Method for treating biomass for producing cell lysate containing plasmid DNA. US2004/0014098
51. Hoare, M., Levy, M. S., Bracewell, D.G., 2005. Bioprocess engineering issues that would be faced in producing a DNA vaccine at up to 100 m3 fermentation scale for an influenza pandemic. Biotechnology Progress, 21:1577–92.
52. Holmes, D.S., and Quigley, M., 1981. A rapid boiling method for the preparation of bacterial plasmids. Analytical Biochemistry, 114:193–7.
53. Horn, N.A., Meek, J. A., Budahazi, G., and Marquet, M., 1995. Cancer gene therapy using plasmid DNA:purification of DNA for human clinical trials. Human Gene Therapy, 6:565–73.
54. Hu, X., Ma, Q., and Zhang, S., 2006. Biopharmaceuticals in China. Biotechnology Journal, 1:1215–24.
55. Huber, H., Weigl, G., and Buchinger, W., 2005. WO2005097990
56. Iuliano, S., Fisher, J. R., Chen, M., and Kelly, W.J., 2002. Rapid analysis of a plasmid by hydrophobic-interaction chromatography with a non-porous resin. Journal of Chromatography A, 972:77–86.
57. Jungbauer, A., and Hahn, R., 2004. Monoliths for fast bioseparation and bioconversion and their applications in biotechnology. Journal of Separation Science, 27:767–78.
58. Jungbauer, A., and Hahn, R., 2008. Polymethacrylate monoliths for preparative and industrial separation of biomolecular assemblies. Journal of Chromatography A, 1184:62–79.
59. Jungbauer, A., Machold, C., and Hahn, R., 2005. Hydrophobic interaction chromatography of proteins. III. Unfolding of proteins upon adsorption. Journal of Chromatography A, 1079:221–8.
60. Kaslow, DC. 2004. A potential disruptive technology in vaccine development:gene-based vaccines and their application to infectious diseases. Transactions of the Royal Society of Tropical Medicine and Hygiene, 98:593–601.
61. Kodihalli, S., Goto, H., Kobasa, D.L., 1999. DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice. The Journal of Virology, 73:2094–8.
62. Kong, S., Rock, C. F., Booth, A., 2008. Large-scale plasmid DNA processing:evidence that cell harvesting and storage methods affect yield of supercoiled plasmid DNA. Biotechnology and Applied Biochemistry, 51:43–51.
63. Lahijani, R., Hulley, G., Soriano, G., Horn, N.A., and Marquet, M., 1996. High-yield production of pBR322-derived plasmids intended for human gene therapy by employing a temperature-controllable point mutation. Human Gene Therapy, 7:1971–80.
64. Lee, A.L., and Sagar, S., 1999. A method for large scale plasmid purification. WO96/36706
65. Lee, T.W., Matthews, D.A., and Blair, G.E., 2005. Novel molecular approaches to cystic fibrosis gene therapy. Biochemical Journal, 387:1–15.
66. Levy, M.S., O'kennedy, R.D., Ayazi-Shamlou, P., and Dunnill, P., 2000. Biochemical engineering approaches to the challenges of producing pure plasmid DNA. Trends in Biotechnology, 18:296–305.
67. Li, L.Z., Liu, Y., Sun, M.S., and Shao, YM., 2007. Effect of salt on purification of plasmid DNA using size-exclusion chromatography. Journal of Chromatography A, 1139:228–35.
68. Li, Y., Dong, X-Y., and Sun, Y., 2005. High-speed chromatographic purification of plasmid DNA with a customized biporous hydrophobic adsorbent. Biochemical Engineering Journal, 27:33–9.
69. Lin-Chao, S., and Bremer, H., 1986. Effect of the bacterial growth rate on replication control of plasmid pBR322 in Escherichia coli. Molecular Genomics and Genetics, 203:143–9.
70. Listner, K., Bentley, L., Okonkowski, J., 2006. Development of a highly productive and scalable plasmid DNA production platform. Biotechnology Progress, 22:1335–45.
71. Liu, M.A., 2003. DNA vaccines:a review. Journal of Internal Medicine, 253:402–10.
72. Ljunglof, A., Bergvall, P., Bhikhabhai, R., and Hjorth, R., 1999. Direct visualisation of plasmid DNA in individual chromatography adsorbent particles by confocal scanning laser microscopy. Journal of Chromatography A, 844:129–35.
73. Lowe, C.R., Lowe, A.R., and Gupta, G., 2001. New developments in affinity chromatography with potential application in the production of biopharmaceuticals. Journal of Biochemical and Biophysical Methods, 49:561–74.
74. Mallik, R., and Hage, D.S., 2006. Affinity monolith chromatography. Journal of Separation Science, 29:1686–704.
75. Manthorpe, M., Hobart, P., Hermanson, G., 2005. Plasmid vaccines and therapeutics:from design to applications. Advances in Biochemical Engineering Biotechnology, 99:41–92.
76. Martin, J.E., Sullivan, N. J., Enama, M.E., 2006. A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial. Clinical and Vaccine Immunology, 13:1267–77.
77. Mccarthy, S.M., Gilar, M., and Gebler, J., 2009. Reversed-phase ion-pair liquid chromatography analysis and purification of small interfering RNA. Analytical Biochemistry, In press
78. Mcdonnell, W.M., and Askari, F.K., 1996. DNA vaccines. The New England Journal of Medicine, 334:42–5.
79. Micard, D., Sobrier, M. L., Couderc, J.L., and Dastugue, B., 1985. Purification of RNA-free plasmid DNA using alkaline extraction followed by Ultrogel A2 column chromatography. Analytical Biochemistry, 148:121–6.
80. Morishita, R., Aoki, M., Hashiya, N., 2004. Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Hypertension, 44:203–9.
81. Mountain, A., 2000. Gene therapy:the first decade. Trends in Biotechnology, 18:119–28.
82. Murphy, J.C., Wibbenmeyer, J. A., Fox, G.E., and Willson, R.C., 1999. Purification of plasmid DNA using selective precipitation by compaction agents. Nature Biotechnology, 17:822–3.
83. Murphy, J.C., Fox, G.E., and Willson, R.C., 2003a. Enhancement of anion-exchange chromatography of DNA using compaction agents. Journal of Chromatography A, 984:215–21.
84. Murphy, J.C., Jewell, D. L., White, K. I., Fox, G.E., and Wilsson, R.C., 2003b. Nucleic acid separations utilizing immobilized metal affinity chromatography. Biotechnology Progress, 19:982–6.
85. Mwau, M., Cebere, I., Sutton, J., 2004. A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials:stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans. Journal of General Virology, 85:911–9.
86. O'kennedy, R.D., Baldwin, C., and Keshavarz-Moore, E., 2000. Effects of growth medium selection on plasmid DNA production and initial processing steps. Journal of Biotechnology, 76:175–83.
87. O'MAHONY, K., Freitag, R., Hilbrig, F., Muller, P., and Schumacher, I., 2005. Proposal for a better integration of bacterial lysis into the production of plasmid DNA at large scale. Journal of Biotechnology, 119:118–32.
88. O'Mahony, K., Freitag, R., Hilbrig, F., Schumacher, I., and Muller, P., 2007. Integration of bacteria capture via filtration and in situ lysis for recovery of plasmid DNA under industry-compatible conditions. Biotechnology Progress, 23:895–03.
89. Palecek, E., Brazda, V., Jagelska, E., 2004. Enhancement of p53 sequence-specific binding by DNA supercoiling. Oncogene, 23:2119–27.
90. Passarinha, L.A., Diogo, M. M., Queiroz, J.A. 2006. Production of ColE1 type plasmid by Escherichia coli DH5 alpha cultured under nonselective conditions. Journal of Microbiology and Biotechnology, 16:20–4.
91. Patil, S.D., Rhodes, D.G., and Burgess, D.J., 2005. DNA-based therapeutics and DNA delivery systems:a comprehensive review. The AAPS Journal, 7:E61–77.
92. Phue, J.N., Lee, S. J., Trinh, L., and Shiloach, J., 2008. Modified Escherichia coli B (BL21), a superior producer of plasmid DNA compared with Escherichia coli K (DH5alpha. Biotechnology Bioengineering, 101:831–6.
93. Platonova, G.A., and Tennikova, TB., 2005. Chromatographic investigation of macromolecular affinity interactions. Journal of Chromatography A, 1065:75–81.
94. Powell, R.J., Simons, M., Mendelsohn, F.O., 2008. Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia. Circulation, 118:58–65.
95. Prather, K.J., Sagar, S., Murphy, J., and Chartrain, M., 2003. Industrial scale production of plasmid DNA for vaccine and gene therapy:plasmid design, production, and purification. Enzyme and Microbial Technology, 33:865–83.
96. Prazeres, D.M.F., Schluep, T., and Cooney, C., 1998. Preparative purification of supercoiled plasmid DNA using anion-exchange chromatography. Journal of Chromatography A, 806:31–45.
97. Prazeres, D.M.F., Ferreira, G. N., Monteiro, G. A., Cooney, C.L., and Cabral, J.M., 1999. Large-scale production of pharmaceutical-grade plasmid DNA for gene therapy:problems and bottlenecks. Trends in Biotechnology, 17:169–74.
98. Prazeres, D.M.F., and Ferreira, G.N.M., 2004. Design of flowsheets for the recovery and purification of plasmids for gene therapy and DNA vaccination. Chemical Engineering Process, 43:615–30.
99. Przybylowski, M., Bartido, S., BORQUEZ-OJEDA, O., Sadelain, M., and Riviere, I., 2007. Production of clinical-grade plasmid DNA for human Phase I clinical trials and large animal clinical studies. Vaccine, 25:5013–24.
100. Queiroz, J.A., Tomaz, C.T., and Cabral, J.M., 2001. Hydrophobic interaction chromatography of proteins. Journal of Biotechnology, 87:143–59.
101. Raymond, G.J., Bryant, P. K., Nelson, A., and Johnson, J.D., 1988. Large-scale isolation of covalently closed circular DNA using gel filtration chromatography. Analytical Biochemistry, 173:125–33.
102. Rolland, A., 2005. Gene medicines:the end of the beginning?. Advanced Drug Delivery Reviews, 57:669–73.
103. Rosenberg, S.A., Yang, J. C., Sherry, R.M., 2003. Inability to immunize patients with metastatic melanoma using plasmid DNA encoding the gp100 melanoma-melanocyte antigen. Human Gene Therapy, 14:709–14.
104. Rozkov, A., Avignone-Rossa, C.A., Ertl, P.F., 2004. Characterization of the metabolic burden on Escherichia coli DH1 cells imposed by the presence of a plasmid containing a gene therapy sequence. Biotechnology and Bioengineering, 88:909–15.
105. Schiel, J.E., Mallik, R., Soman, S., Joseph, K.S., and Hage, D.S., 2006. Applications of silica supports in affinity chromatography. Journal of Separation Science, 29:719–37.
106. Schleef, M., and Schmidt, T., 2004. Animal-free production of ccc-supercoiled plasmids for research and clinical applications. Journal of Gene Medicine, 6:S45–53.
107. Schluep, T., and Cooney, C.L., 1998. Purification of plasmids by triplex affinity interaction. Nucleic Acids Research, 26:4524–8.
108. Schmidt, T., Schleef, M., Friehs, K., and Flaschel, E., 2002. Method for producing homogeneus nucleic acid multimers for use in pharmaceutical compositions. WO02/062987
109. Sebestyen, M.G., Hegge, J. O., Noble, M.A., 2007. Progress toward a nonviral gene therapy protocol for the treatment of anemia. Human Gene Therapy, 18:269–85.
110. Seo, J.H., and Bailey, J.E., 1985. Effects of recombinant plasmid content on growth properties and cloned gene product formation in Escherichia coli. Biotechnology and Bioengineering, 27:1668–74.
111. Sheets, E.E., Urban, R. G., Crum, C.P., 2003. Immunotherapy of human cervical high-grade cervical intraepithelial neoplasia with microparticle-delivered human papillomavirus 16 E7 plasmid DNA. American Journal of Obstetrics and Gynecology, 188:916–26.
112. Singer, A., Eiteman, M.A., and Altman, E., 2009. DNA plasmid production in different host strains of Escherichia coli. Journal of Industrial Microbiology and Biotechnology, 36:521–30.
113. Sofer, G., and Hager, L., “ Handbook of process chromatography ”. In A guide to optimization, scale-up and validation
114. Sousa, A., Sousa, F., Prazeres, D.M.F., and Queiroz, J.A., 2009a. Histidine affinity chromatography of homo-oligonucleotides. Role of multiple interactions on retention. Biomedical Chromatography, 23:745–53.
115. Sousa, A., Sousa, F., and Queiroz, J.A., 2009b. Selectivity of arginine chromatography in promoting different interactions using synthetic oligonucleotides as model. Journal of Separation Science, 32:1665–72.
116. Sousa, F., Tomaz, C. T., Prazeres, D.M.F., and Queiroz, J.A., 2005. Separation of supercoiled and open circular plasmid DNA isoforms by chromatography with a histidine-agarose support. Analytical Biochemistry, 343:183–5.
117. Sousa, F., Freitas, S., Azzoni, A. R., Prazeres, D.M.F., and Queiroz, J.A., 2006. Selective purification of supercoiled plasmid DNA from clarified cell lysates with a single histidine-agarose chromatography step. Biotechnology and Applied Biochemistry, 45:131–40.
118. Sousa, F., Prazeres, D.M.F., and Queiroz, J.A., 2007. Circular dichroism investigation of the effect of plasmid DNA structure on retention in histidine chromatography. Archives of Biochemistry and Biophysics, 467:154–62.
119. Sousa, F., Matos, T., Prazeres, D.M.F., and Queiroz, J.A., 2008a. Specific recognition of supercoiled plasmid DNA in arginine affinity chromatography. Analytical Biochemistry, 374:432–4.
120. Sousa, F., Prazeres, D.M.F., and Queiroz, J.A., 2008b. Affinity chromatography approaches to overcome the challenges of purifying plasmid DNA. Trends in Biotechnology, 26:518–25.
121. Sousa, F., Prazeres, D.M.F., and Queiroz, J.A., 2008c. Binding and elution strategy for improved performance of arginine affinity chromatography in supercoiled plasmid DNA purification. Biomedical Chromatography, 23:160–5.
122. Sousa, F., Prazeres, D.M.F., and Queiroz, J.A., 2009c. Improvement of transfection efficiency by using supercoiled plasmid DNA purified with arginine affinity chromatography. Journal of Gene Medicine, 11:79–88.
123. Stadler, J., Lemmens, R., and Nyhammar, T., 2004. Plasmid DNA purification. Journal of Gene Medicine, 6:S54–66.
124. Subbarao, K., Murphy, B.R., and Fauci, A.S., 2006. Development of effective vaccines against pandemic influenza. Immunity, 24:5–9.
125. Tan, L., Lai, W. B., Lee, C. T., Kim, D.S., and Choe, W.S., 2007. Differential interactions of plasmid DNA, RNA and endotoxin with immobilised and free metal ions. Journal of Chromatography A, 1141:226–34.
126. Tangney, M., Casey, G., Larkin, J.O., 2006. Non-viral in vivo immune gene therapy of cancer:combined strategies for treatment of systemic disease. Cancer Immunology Immunotherapy, 55:1443–50.
127. Teeters, M.A., Conrardy, S. E., Thomas, B. L., Root, T.W., and Lightfoot, E.N., 2003. Adsorptive membrane chromatography for purification of plasmid DNA. Journal of Chromatography A, 989:165–73.
128. Tejeda-Mansir, A., and Montesinos, R.M., 2008. Upstream processing of plasmid DNA for vaccine and gene therapy applications. Recent Patents on Biotechnology, 2:156–72.
129. Thatcher, D.R., Hitchcock, A. G., Hanak, J.A., and Varley, D., 1997. Method of plasmid DNA production and purification patent. WO 97/29190
130. Theodossiou, I., Sondergaard, M., and Thomas, O.R., 2001. Design of expanded bed supports for the recovery of plasmid DNA by anion exchange adsorption. Bioseparation, 10:31–44.
131. Theodossiou, I., and Thomas, O.R., 2002. DNA-induced inter-particle cross-linking during expanded bed adsorption chromatography. Impact on future support design. Journal of Chromatography A, 971:73–86.
132. Thwaites, E., Burton, S.C., and Lyddiatt, A., 2002. Impact of the physical and topographical characteristics of adsorbent solid-phases upon the fluidised bed recovery of plasmid DNA from Escherichia coli lysates. Journal of Chromatography A, 943:77–90.
133. Tiainen, P., Galaev, I., and Larsson, P.O., 2007a. Plasmid adsorption to anion-exchange matrices:Comments on plasmid recovery. Biotechnology Journal, 2:726–35.
134. Tiainen, P., Gustavsson, P. E., Ljunglof, A., and Larsson, P.O., 2007b. Superporous agarose anion exchangers for plasmid isolation. Journal of Chromatography A, 1138:84–94.
135. Tiainen, P., Gustavsson, P. E., Mansson, M.O., and Larsson, P.O., 2007c. Plasmid purification using non-porous anion-exchange silica fibres. Journal of Chromatography A, 1149:158–68.
136. Unsal, E., Bahar, T., Tuncel, M., and Tuncel, A., 2000. DNA adsorption onto polyethylenimine-attached poly(p-chloromethylstyrene) beads. Journal of Chromatography A, 898:167–77.
137. Urthaler, J., Schlegl, R., Podgornik, A., 2005. Application of monoliths for plasmid DNA purification development and transfer to production. Journal of Chromatography A, 1065:93–106.
138. Vo-Quang, T., Malpiece, Y., Buffard, D., 1985. Rapid large-scale purification of plasmid DNA by medium or low pressure gel filtration. Application:construction of thermoamplifiable expression vectors. Bioscience Reports, 5:101–11.
139. Wang, R., Doolan, D. L., Le, T.P., 1998. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science, 282:476–80.
140. Weide, B., Garbe, C., Rammensee, H.G., and Pascolo, S., 2008. Plasmid DNA- and messenger RNA-based anti-cancer vaccination. Immunology Letters, 115:33–42.
141. Wicks, I.P., Howell, M. L., Hancock, T., 1995. Bacterial lipopolysaccharide copurifies with plasmid DNA:implications for animal models and human gene therapy. Human Gene Therapy, 6:317–23.
142. Wils, P., Escriou, V., Warnery, A., 1997. Efficient purification of plasmid DNA for gene transfer using triple-helix affinity chromatography. Gene Therapy, 4:323–30.
143. Wolff, J.A., Malone, R. W., Williams, P., 1990. Direct gene transfer into mouse muscle in vivo. Science, 247:1465–8.
144. Woodgate, J., Palfrey, D., Nagel, D. A., Hine, A.V., and Slater, N.K., 2002. Protein-mediated isolation of plasmid DNA by a zinc finger-glutathione S-transferase affinity linker. Biotechnology and Bioengineering, 79:450–6.
145. Xiao, Y., Rathore, A., O'Connell, J.P., and Fernandez, E.J., 2007. Generalizing a two-conformation model for describing salt and temperature effects on protein retention and stability in hydrophobic interaction chromatography. Journal of Chromatography A, 1157:197–206.
146. Xu, Z.N., Shen, W. H., Chen, H., and Cen, P.L., 2005. Effects of medium composition on the production of plasmid DNA vector potentially for human gene therapy. Journal of Zhejiang University Science B, 6:396–400.
147. Yau, S.Y., Keshavarz-Moore, E., and Ward, J., 2008. Host strain influences on supercoiled plasmid DNA production in Escherichia coli:Implications for efficient design of large-scale processes. Biotechnology and Bioengineering, 101:529–44.
148. Yonenaga, Y., Mori, A., Fujimoto, A., 2007. The administration of naked plasmid DNA into the liver induces antitumor innate immunity in a murine liver metastasis model. Journal of Gene Medicine, 9:299–307.
149. Zanin, M.P., Webster, D.E., and Wesselingh, S.L., 2007. A DNA prime, orally delivered protein boost vaccination strategy against viral encephalitis. Journal of Neurovirology, 13:284–9.
150. Zhu, K., Jin, H., Ma, Y., 2005. A continuous thermal lysis procedure for the large-scale preparation of plasmid DNA. Journal of Biotechnology, 118:257–64.